Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
€ 121,00 0.00 (0.00%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionPatten Group, Inc.
Latest Disclosed Ownership17,026 shares
Latest Disclosed Value $ 2,600,722
Patten Group, Inc. reports 0.63% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 24, 2026 - Patten Group, Inc. filed a 13F-HR form disclosing ownership of 17,026 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $2,187,841 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 17,134 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -0.63% during the quarter. The current value of the position is $2,060,146 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 17,026 -108 -0.63 2,601 10.08 0.4521
2026-01-23 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 17,134 321 1.91 2,362 9.55 0.4369
2025-11-10 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 16,813 -40 -0.24 2,156 5.74 0.4197
2025-07-30 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 16,853 -117 -0.69 2,039 7.83 0.4308
2025-05-14 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 16,970 629 3.85 1,892 18.93 0.4335
2025-02-06 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 16,341 -46 -0.28 1,590 -15.61 0.3519
2024-10-08 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 16,387 -126 -0.76 1,885 7.23 0.4186
2024-07-25 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 16,513 403 2.50 1,758 12.77 0.4147
2024-04-17 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 16,110 0 0.00 1,558 -4.18 0.3835
2024-01-10 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 16,110 299 1.89 1,627 0.99 0.4415
2023-10-12 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 15,811 19 0.12 1,611 1.07 0.4812
2023-07-26 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 15,792 0 0.00 1,594 9.71 0.2361
2023-04-06 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 15,792 118 0.75 1,453 2.18 0.4361
2023-02-10 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 15,674 465 3.06 1,422 23.46 0.4466
2022-10-13 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 15,209 0 0.00 1,151 -10.36 0.3954
2022-07-18 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 15,209 9 0.06 1,284 -3.75 0.4114
2022-04-28 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 15,200 791 5.49 1,334 5.87 0.3742
2022-01-20 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 14,409 48 0.33 1,260 7.33 0.3336
2021-11-15 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 14,361 -60 -0.42 1,174 -10.79 0.3452
2021-08-03 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 14,421 -1,176 -7.54 1,316 -1.28 0.3867
2021-04-23 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 15,597 27 0.17 1,333 -9.32 0.4269
2021-02-02 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 15,570 -230 -1.46 1,470 6.99 0.3968
2020-10-19 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 15,800 55 0.35 1,374 -0.07 0.5361
2020-07-20 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 15,745 -473 -2.92 1,375 2.84 0.5916
2020-04-16 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 16,218 -1,130 -6.51 1,337 -18.62 0.6914
2020-01-14 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 17,348 -107 -0.61 1,643 8.31 0.6125
2019-10-22 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 17,455 -85 -0.48 1,517 -5.31 0.6165
2019-07-11 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 17,540 221 1.28 1,602 -3.78 0.6551
2019-05-14 2019-03-31 13F NOVARTIS A G ADR 66987V109 17,319 223 1.30 1,665 13.50 0.7167
2019-02-12 2018-12-31 13F Novartis CS 66987V109 17,096 -794 -4.44 1,467 -4.80 0.6956
2018-11-14 2018-09-30 13F Novartis CS 66987V109 17,890 -660 -3.56 1,541 9.99 0.5876
2018-08-13 2018-06-30 13F Novartis CS 66987V109 18,550 -851 -4.39 1,401 -10.71 0.5613
2018-05-11 2018-03-31 13F Novartis CS 66987V109 19,401 -96 -0.49 1,569 -4.15 0.6437
2018-02-02 2017-12-31 13F Novartis CS 66987V109 19,497 -541 -2.70 1,637 -4.83 0.6484
2017-12-12 2017-09-30 13F/A-1 Novartis CS 66987V109 20,038 0 0.00 1,720 1.00 0.6958
2017-11-14 2017-09-30 13F Novartis CS 66987V109 59,882 39,844 1,720 695,812.5837
2017-08-14 2017-06-30 13F Novartis CS 66987V109 20,038 -1,939 -8.82 1,703 5.12 0.6902
2017-05-30 2017-03-31 13F Novartis CS 66987V109 21,977 -686 -3.03 1,620 -0.98 0.7031
2017-02-10 2016-12-31 13F Novartis CS 66987V109 22,663 -2,270 -9.10 1,636 -14.39 0.7341
2016-11-14 2016-09-30 13F Novartis CS 66987V109 24,933 -115 -0.46 1,912 -7.50 0.8973
2016-08-15 2016-06-30 13F Novartis CS 66987V109 25,048 449 1.83 2,067 16.00 0.9672
2016-05-13 2016-03-31 13F Novartis CS 66987V109 24,599 810 3.40 1,782 -12.95 0.8455
2016-02-17 2015-12-31 13F Novartis CS 66987V109 23,789 -1,000 -4.03 2,047 -10.18 0.9840
2015-11-16 2015-09-30 13F Novartis CS 66987V109 24,789 75 0.30 2,279 -6.26 1.1731
2015-08-24 2015-06-30 13F Novartis CS 66987V109 24,714 -200 -0.80 2,430 -1.10 1.1544
2015-05-06 2015-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 24,914 -1,225 -4.69 2,457 1.45 1.2582
2015-02-18 2014-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 26,139 26,139 2,422 1.1762
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.